ESR1 and breast cancer: The impact on Ras has not been analyzed, but increased phospho-RASAL2 was detected in aggressive ER (estrogen receptor) negative breast cancer cells, leading authors to propose that this modification could shift the tumor-suppressive function of the protein to a tumor-promoting activity, possibly explaining some contradictory observations on its role in cancer [29].